Tiziana Life Sciences PLC (LON:TILS – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 58.50 ($0.78) and traded as low as GBX 45 ($0.60). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.78), with a volume of 297,127 shares.
Tiziana Life Sciences Price Performance
The firm has a market capitalization of £113.85 million and a P/E ratio of -3.59. The stock’s fifty day simple moving average is GBX 58.50 and its 200 day simple moving average is GBX 58.50. The company has a debt-to-equity ratio of 2.36, a current ratio of 6.54 and a quick ratio of 6.41.
Tiziana Life Sciences Company Profile
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
See Also
- Five stocks we like better than Tiziana Life Sciences
- Stock Market Sectors: What Are They and How Many Are There?
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- What is a buyback in stocks? A comprehensive guide for investors
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Election Stocks: How Elections Affect the Stock Market
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.